His primary areas of investigation include COPD, Internal medicine, Lung, Spirometry and Pulmonary disease. His COPD research integrates issues from Respiratory disease, Lung volumes, Pathology, Physical therapy and Severity of illness. His work carried out in the field of Internal medicine brings together such families of science as Intensive care, Intensive care medicine and Cardiology.
His study in Cardiology is interdisciplinary in nature, drawing from both Body mass index and Airway. His Lung study incorporates themes from Radiology and Pulmonary function testing. His studies deal with areas such as Female sex and Disease classification as well as Pulmonary disease.
George R. Washko spends much of his time researching Internal medicine, COPD, Lung, Cardiology and Radiology. The various areas that George R. Washko examines in his Internal medicine study include Gastroenterology and Surgery. His biological study deals with issues like Pulmonary disease, which deal with fields such as Intensive care medicine.
His study looks at the relationship between Lung and topics such as Pathology, which overlap with Genome-wide association study. His Cardiology research includes themes of Framingham Heart Study, Body mass index and FEV1/FVC ratio. His study brings together the fields of Lung volumes and Radiology.
The scientist’s investigation covers issues in Internal medicine, Cardiology, COPD, Lung and Spirometry. His research in FEV1/FVC ratio, Cohort, Pulmonary artery, Respiratory system and Pulmonary disease are components of Internal medicine. His research integrates issues of Framingham Heart Study, Interquartile range, Confidence interval and Risk factor in his study of Cardiology.
His studies in COPD integrate themes in fields like Clinical trial, Air trapping, Exacerbation, Transcriptome and Genetic epidemiology. His Exacerbation study also includes fields such as
George R. Washko mainly investigates COPD, Internal medicine, Lung, Cardiology and Framingham Heart Study. The COPD study combines topics in areas such as Exacerbation, Asthma, Ct imaging and Genetic epidemiology. His work in the fields of Lung, such as Interstitial lung disease and Idiopathic pulmonary fibrosis, intersects with other areas such as Abnormality.
In Cardiology, George R. Washko works on issues like Respiratory system, which are connected to Lung function, Chronic bronchitis, Chest ct, Statistical significance and Airway obstruction. His Framingham Heart Study study combines topics from a wide range of disciplines, such as Mediastinum, Radiomics, Radiology, Thoracic imaging and Risk of death. In his research on the topic of FEV1/FVC ratio, Spirometry is strongly related with Diffusing capacity.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Azithromycin for Prevention of Exacerbations of COPD
Richard K. Albert;Richard K. Albert;John Connett;William C. Bailey;Richard Casaburi.
The New England Journal of Medicine (2011)
Chronic obstructive pulmonary disease phenotypes: the future of COPD.
Mei Lan K. Han;Alvar Agusti;Peter M. Calverley;Bartolome R. Celli.
American Journal of Respiratory and Critical Care Medicine (2010)
Chronic Obstructive Pulmonary Disease Exacerbations in the COPDGene Study: Associated Radiologic Phenotypes
MeiLan K. Han;Ella A. Kazerooni;David A. Lynch;Lyrica X. Liu.
An Official American Thoracic Society/European Respiratory Society Statement: Research Questions in Chronic Obstructive Pulmonary Disease
Bartolome R. Celli;Marc Decramer;Jadwiga A. Wedzicha;Kevin C. Wilson.
American Journal of Respiratory and Critical Care Medicine (2015)
Lung Volumes and Emphysema in Smokers with Interstitial Lung Abnormalities
George R. Washko;Gary M. Hunninghake;Isis E. Fernandez;Mizuki Nishino.
The New England Journal of Medicine (2011)
Pulmonary arterial enlargement and acute exacerbations of COPD.
J. Michael Wells;George R. Washko;Mei Lan K. Han;Naseer Abbas.
The New England Journal of Medicine (2012)
Mitophagy-dependent necroptosis contributes to the pathogenesis of COPD
Kenji Mizumura;Kenji Mizumura;Kenji Mizumura;Suzanne M. Cloonan;Suzanne M. Cloonan;Kiichi Nakahira;Kiichi Nakahira;Abhiram R. Bhashyam.
Journal of Clinical Investigation (2014)
Simvastatin for the Prevention of Exacerbations in Moderate-to-Severe COPD
G. J. Criner;John E Connett;S. D. Aaron;R. K. Albert.
The New England Journal of Medicine (2014)
Role of the B-cell response in recovery of mice from primary influenza virus infection.
Walter Gerhard;Krystyna Mozdzanowska;Michelle Furchner;George Washko.
Immunological Reviews (1997)
GOLD 2011 disease severity classification in COPDGene: a prospective cohort study.
MeiLan K. Han;Hana Muellerova;Douglas Curran-Everett;Mark T. Dransfield.
The Lancet Respiratory Medicine (2013)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: